Press ReleaseImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting SUZHOU, China, April 28, 2025 /PRNewswire/ — From April 25 to April… CISION PRNewswireApril 28, 2025
Thunes Raises USD 150 Million in Series D, Led by Apis Partners and Vitruvian Partners SINGAPORE, April 28, 2025 /PRNewswire/ — Thunes, the Smart Superhighway to move… CISION PRNewswireApril 28, 2025
Press ReleaseLG Uplus' KidsTopia Combines AI Edutainment with Ecology and K-POP Content for a New Customer Experience Virtual Tidal Flat Experience: Learn about 120 different species and environments in… CISION PRNewswireApril 28, 2025
Press ReleaseVietnam: A Hub for Accessible World-Class British Transnational Education for Resilient Global Graduates HANOI, Vietnam, April 28, 2025 /PRNewswire/ — Vietnam is emerging as a… CISION PRNewswireApril 28, 2025
Press ReleaseRegister for Free at HK01 AI Transformation Solution Day Empowering Enterprises to Accelerate Digital Transformation and Co-create a Smart Future HONG… CISION PRNewswireApril 28, 2025
2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ — Innovent Biologics,… CISION PRNewswireApril 28, 2025
Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025 CAMBRIDGE, Mass., April 28, 2025 /PRNewswire/ — Nona Biosciences, a global biotechnology… CISION PRNewswireApril 28, 2025
Everest Medicines Announces the "B" Marker Removal from Company's Stock Code, Effective May 2, 2025 SHANGHAI, April 28, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or the… CISION PRNewswireApril 28, 2025
